We reported that complement cascade (CC) becomes activated in bone marrow (BM) during granulocyte colony-stimulating factor (G-CSF) mobilization of hematopoietic stem/progenitor cells (HSPCs) and showed that, although third CC component (C3)-deficient mice are easy mobilizers, fifth CC component (C5)-deficient mice mobilize very poorly. To explain this, we postulated that activation/cleavage of CC releases C3a and C5a anaphylatoxins that differently regulate mobilization. Accordingly, C3a, by enhancing responsiveness of HSPCs to decreasing concentrations of stromal-derived growth factor-1 (SDF-1) in BM, prevents mobilization and promotes their BM retention. Therefore, in this study, we focused on the mobilizationenhancing role of C5a. We found that C5a receptor (C5aR) is not expressed on the surface of HSPCs, and that C5a-mediated promobilization effects are mediated by stimulation of granulocytes. Overall, our data support the following model. First C5aR þ granulocytes are chemoattracted by plasma C5 cleavage fragments, being the first wave of cells leaving BM. This facilitates a subsequent egress of HSPCs. In the next step, after leaving BM, granulocytes undergo degranulation in response to plasma C5a and secrete some cationic peptides (cathelicidin, b-defensin) that, as shown here for the first time, highly enhance the responsiveness of HSPCs to plasma SDF-1 gradient. In conclusion, our data reveal the underappreciated central role of innate immunity in mobilization, in which C5 cleavage fragments through granulocytes orchestrate this process.
Introduction
Hematopoietic stem/progenitor cells (HSPCs) circulate in peripheral blood (PB) under steady state conditions at very low levels to keep a pool of stem cells in balance in the bone marrow (BM) microenvironment, which is located in distant bones. Therefore, PB could be envisioned as a highway through which HSPCs relocate in the organism between hematopoietic BM endosteal and endothelial niches. Furthermore, after they enter tissues, these circulating HSPCs may return to the PB through the lymphatic system and thoracic duct. 1 This route of 'circulation/tissue patrolling' is enforced during infection, 2 wherein mobilized HSPCs could be recruited to affected peripheral tissues and give rise to tissue-resident myeloid and dendritic cells. In addition to infection, HSPCs are mobilized from BM into PB during tissue injury 3, 4 and after administration of some pharmacological agents (for example, granulocyte colony-stimulating factor (G-CSF)). [5] [6] [7] [8] The molecular mechanisms controlling the mobilization of HSPCs are still not well understood. However, the attenuation of the stromal-derived growth factor-1 (SDF-1)-CXCR4 interaction between BM-secreted SDF-1 and HSPC-expressed CXCR4 9 and the adhesive interaction between very late antigen-4 (VLA-4; a 1 b 4 integrin) expressed on HSPCs and its ligand vascular adhesion molecule-1 (VCAM-1; CD106), which is expressed in the BM microenvironment, have a crucial role in this process. 9 Augmenting evidence shows that HSPC mobilization is regulated by elements of innate immunity, in particular by complement cascade (CC) protein cleavage fragments, [10] [11] [12] neutrophils 13, 14 and toll receptors, 15 all of which have a pivotal and, until recently, underappreciated role in this process. To support this, work from our laboratory showed that CC is in fact activated during mobilization 16, 17 and that several CC cleavage fragments (for example, C3a, desArg C3a, C5a, desArg C5a anaphylatoxins) may modulate this process. We noticed that, although C3 cleavage fragments (C3a, desArg C3a) increase retention of HSPCs in BM, 11, 18 C5 cleavage fragments (C5a, desArg C5a) enhance egress of HSPCs into PB. 12, 19 This was evident in mobilization studies conducted in C3-and C5-deficient animals, which revealed that C3-deficient (C3 À/À ) mice are easy mobilizers 10, 17 and C5-deficient (C5 À/À ) mice are poor mobilizers by contrast. 12, 19 Furthermore, it is also well known that granulocytes, in order to mobilize HSPCs, have to release several proteloytic enzymes that perturb the SDF-1-CXCR4 and VLA-4-VCAM-1 retention axes. 20, 21 Granulocytes are also the first cells that egress from BM during mobilization and the mobilization process is severely defective in leukocyte-deficient animals. 22, 23 Finally, mobilization studies in a murine model revealed that mobilization is somehow facilitated by the activation of toll receptors on BM myeloid cells through lipopolysaccharide released by intestinal anaerobic bacteria 24 or by toll receptors binding polysaccharides. 25, 26 In this paper, we focus on the importance of CC and granulocytes, two crucial components of innate immunity, in the mobilization of HSPCs. Overall, our data support the central role of granulocytes in orchestration of mobilization, as well as shed more light on novel granulocyte and C5 cleavage fragmentdirected mechanisms that regulate the egress of HSPCs.
Materials and methods

Animals
Pathogen-free, 4-to 6-week-old C5 À/À -, C5 þ / þ -and C5a receptor-deficient (C5aR À/À ) mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA, http://www.jax.org). C57BL/6
and Balb/c mice were purchased from the National Cancer Institute (Frederick, MD, USA, http://www.cancer.gov). All mice were adapted over 2 weeks and used for experiments at age 6-8 weeks. Animal studies were approved by the Animal Care and Use Committee of the University of Louisville (Louisville, KY, USA).
Mobilization
Mice were injected subcutaneously with 250 mg/kg of human G-CSF (Amgen, Thousand Oaks, CA, USA, http://www.amgen. com) daily for 6 days. For zymosan mobilization, mice were injected intravenously with 0.5 mg of zymosan. At 6 h after the last G-CSF administration or at 1 h after zymosan injection, mice were bled from the retro-orbital plexus for complete blood count, and 450 ml of PB was obtained from the vena cava with a 25-G needle and 1 ml syringe containing 50 ml of 100 mM ethylenediaminetetraacetic acid.
Complete blood counts
Fifty microliters of PB was taken from the retro-orbital plexus of mice and collected into microvette ethylenediaminetetraacetic acid-coated tubes (Sarstedt Inc., Newton, NC, http://www. sarstedt.com/php/main.php). Samples were run within 2 h of collection on a HemaVet 950 (Drew-Scientific Inc., Oxford, CT, http://www.drew-scientific.com).
Colony-forming unit-granulocytes/macrophage (CFU-GM) assay
Red blood cells were lysed with BD Pharm Lyse buffer (BD Biosciences, San Jose, CA, USA, http://www.bdbiosciences. com). Nucleated cells were subsequently washed twice and used for CFU-GM colonies as described elsewhere. 10 Briefly, cells were resuspended in human methylcellulose base media provided by the manufacturer (R&D Systems, Inc., Minneapolis, MN, USA, http://www.rndsystems.com), supplemented with 25 ng/ml recombinant murine granulocyte macrophage colony-stimulating factor and 10 ng/ml recombinant murine interleukin-3 (mIL-3) (Millipore, Billerica, MA, USA, http:// www.millipore.com). Cultures were incubated for 7 days, at which time they were scored for the number of CFU-GM colonies under an inverted microscope.
Evaluation of HSPC mobilization
The formula used for evaluation of circulating CFU-GM and Sca-1 þ /c-Kit þ /Lin À (SKL) cells is as follows: ((number of white blood cells (WBCs) Â number of CFU-GM colonies)/number of WBCs plated ¼ number of CFU-GM per microliter of PB) and ((number of WBCs Â number of SKL cells)/number of gated WBCs ¼ number of SKL cells per microliter of PB), respectively.
Transmission electron microscopy (TEM)
TEM analysis was performed as described elsewhere. 27 Briefly, mice were bled and perfused with 50 ml Krebs-Ringer bicarbonate buffer and then fixed by a continuous infusion of 50 ml carcodylate buffer (0.1 M) through the left ventricle at 6 h after final G-CSF administration. BM tissue was harvested carefully and additionally fixed in 0.25 m glutaraldehyde in cacodylate buffer (pH 7.4) for 2 h at 4 1C, postfixed in 0.04 M OsO 4 and dehydrated in ethyl alcohol (30-96%) and 100% acetone. Fixed tissues were subsequently embedded in LX112 and sectioned at 800 Å , stained with uranyl acetate and lead citrate and viewed on a Philips CM10 TEM operating at 60 kV.
Bone marrow nucleated cells (BMNCs)
BMNCs were prepared by flushing femurs and tibias of pathogen-free, 6-to 8-week-old mice without enzymatic digestion. They were lysed with BD Pharm Lyse buffer (BD Biosciences) to remove red blood cells, washed and resuspended in appropriate media for further analysis.
Fluorescence-activated cell sorting (FACS) analysis
BMNC staining was carried out in a medium containing 2% fetal bovine serum (FBS). All monoclonal antibodies were added at saturating concentrations and cells were incubated for 30 min on ice, washed twice, resuspended in staining solution at a concentration of 5 Â 10 6 cells per ml and subjected to analysis using LSR II (Becton Dickinson, Mountainview, CA, USA). The following anti-mouse antibodies were used to detect fluorescein isothiocyanate-anti-CD117 (c-Kit) (clone 2B8, BioLegend, San Diego, CA, USA) and Phycoerythrin-Cy5 anti-mouse Ly-6A/E (Sca-1) (clone D7, eBioscience San Diego, CA, USA). All antimouse lineage markers (Lin) were conjugated by Phycoerythrin and purchased from the same company (BD Biosciences): anti-CD45R/B220 (clone RA3-6B2); anti-Gr-1 (clone RB6-8C5); anti-t-cell receptor b (TCRb; clone H57-597); anti-TCRgd (clone GL3); anti-CD11b (clone M1/70); and anti-Ter-119 (clone TER-119).
Sorting of BMNCs
SKL cells and granulocytes (Gr-1 þ ) were purified as described elsewhere. 27 Briefly, BMNCs (1 Â 10 8 cells per ml) were resuspended in Roswell Park Memorial Institute medium containing 2% heat-inactivated FBS (GIBCO, Grand Island, NY, USA), 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid buffer (GIBCO) and antibiotics (Mediatech Inc., Manassas, VA, USA, http://www.cellgro.com), and incubated with saturating concentrations of directly labeled monoclonal antibodies for 30 min on ice, washed twice and sorted by multiparameter, live sterile cell sorting (MoFlo, Dako A/S, Fort Collins, CO, USA).
Transwell migration assay
Transwell migration assay was performed as described elsewhere. 10 Briefly, unless otherwise indicated, RBC-lysed BMNCs from C57BL/6 mice were resuspended in assay media (Roswell Park Memorial Institute medium containing 0.5% bovine serum albumin) and equilibrated for 10 min at 37 1C. Assay media of 650 microliters, containing test reagents in the presence or absence of 50 ng/ml SDF-1 (PeproTech, Rocky Hill, NJ, USA), were added to the lower chambers of a Costar Transwell 24-well plate (Costar Corning, Cambridge, MA, USA). C3a, C5a and desArg C5a were purchased from Calbiochem (La Jolla, CA, USA). Other test reagents, LL-37 (AnaSpec Inc., San Jose, CA, USA) and b-defensin-2 (Chemicon, Themcula, CA, USA), were also purchased. Aliquots of cell suspension (1 Â 10 6 cells per 100 ml) were loaded onto the upper chambers with 5-mm pore filters, which were incubated for 3 h (37 1C, 95% humidity, 5% CO 2 ). Cells from the lower chambers were scored using FACS analysis for migration of BMNCs to test reagents. The results are presented as a migration index, that is, the ratio of the number of cells that migrated toward the medium containing test reagents to the number of cells that migrated toward the medium alone. In some experiments, migrated cells harvested from the lower chambers were plated in semisolid clonogenic assays supplemented with cytokines and were stimulated to grow CFU-GMs as described elsewhere. 12 To evaluate the influence of lipid raft formation on cell migration, cells were preincubated before the transwell migration assay with molecules (1.0 or 2.5 mM methyl-b-cyclodextrin (MbCD, Sigma, St Louis, MO, USA)) that disturb lipid raft formation. 10
C5aR expression analysis
Expression of C5aR was evaluated by FACS as described below. C5aR was detected on BM and SKL cells with biotinylated rat antimurine C5aR (clone 10/92, Abcam, Cambridge, MA, USA) and Streptavidin-Allophycocyanin/Cy7 (APC/Cy7) (Biolegend), washed and subjected to analysis using a LSR II (Becton Dickinson).
Reverse transcriptase-polymerase chain reaction
Total mRNA was isolated using an RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA) from each of the 20 000 sorted cell populations. Messenger RNA was reverse transcribed with 500 U of Moloney murine leukemia virus reverse transcriptase (MoMLV-RT). The resulting cDNA fragments were amplified using 5 U of Thermus aquaticus (Taq) polymerase. Primer sequences for b-2 microglobulin (b2M) were forward primer: 5 0 -CATACGCCTGCAGAGTTAAGC-3 0 and reverse primer: 5 0 -GATCACATGTCTCGATCCVAGTAG-3 0 . For C5aR, primer sequences were forward primer: 5 0 -TCCTGCTGCTGGCTACC ATT-3 0 and reverse primer: 5 0 -AGTCCCGCGGACCTTCTG-3 0 . For C5L2, primer sequences were forward primer: 5 0 -ATGGCCG ACTTGCTTTGTTG-3 0 and reverse primer: 5 0 -TGGCCA GTGGCCCTTTT-3 0 . PCR products were run in 2% agarose gels containing ethidium bromide and photographed under UV light. The sizes of PCR products were verified against 100-bp DNA ladders.
Isolation of lipid rafts
Human pre-B-cell line, Nalm-6 (5 Â 10 7 ), was lysed in 300 ml MEB buffer (150 mM NaCl, 20 mM MES, pH 6.5) containing 1% Triton X-100 and protease inhibitors (500 mM phenylmethylsulfonyl fluoride and 5 mM iodoacetamide) for 1 h on ice. The cells were mixed with an equal volume of 80% sucrose in MEB and were placed at the bottom of a centrifuge tube. Samples were overlain with 30 and 5% sucrose in MEB and were centrifuged at 100 000 g for 17 h. Fractions were gently removed from the top of the gradient and n-octylglucoside was added to each fraction (60 mM final) to solubilize rafts. Western blot analysis was carried out using standard techniques with a CXCR4 antibody (Serotec, Oxford, UK) and Lyn antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Statistical analysis
Arithmetic means and s.d. were calculated using Instat 1.14 software (Graphpad, San Diego, CA, USA). Statistical significance was defined as Po0.05. Data were analyzed using Student's t-test for unpaired samples.
Results
C5-deficient mice are poor mobilizers
Both C5 þ / þ and C5 À/À mice were mobilized by long-term (6 days) G-CSF-or short-term (1 h) zymosan-induced protocol. Subsequently, after the last G-CSF injections and 1 h after zymosan administration, we evaluated the number of circulating neutrophils, CFU-GM progenitors and SKL cells in mobilized animals. We noticed that C5 À/À mice showed impaired mobilization response to G-CSF ( Figure 1a ) as well as to zymosan (Figure 1b) .
These observations were subsequently confirmed by TEM. 
Effects of C5a and desArg C5a on chemotaxis of BMNCs
As C5 À/À mice are poor mobilizers, we hypothesized that CC cleavage fragments, C5a and desArg C5a anaphylatoxins, may have an important role here. To address this question, we first performed chemotactic assays of wt BMNCs to C5 and desArg C5a gradient. Next, because another anaphylatoxin, C3a (C3 cleavage product), enhances responsiveness of BMNCs to a low gradient of SDF-1, 10, 16 we evaluated whether a similar phenomenon will occur for C5a and desArg C5a. Figure 3a shows that desArg C5a, but not C5a, chemoattracts BMNCs alone or in an additive manner with SDF-1. In contrast, no effect of C5a and desArg C5a was observed on CFU-GM chemotaxis (Figure 3b ). In control experiments, C3a did not chemoattract CFU-GM progenitors alone; however, as expected, it increased responsiveness of BMNCs to a low dose of SDF-1 (Figure 3b ). These data show that desArg C5a, but not C5a, chemoattracts BMNCs; however, both C5 cleavage fragments do not affect CFU-GM migration.
It is also known that C5a and desArg C5a bind to two G-proteincoupled C5aR and C5L2 receptors. To address the importance of both receptors in this process, we performed chemotaxis with BMNCs isolated from wild-type (wt) and C5aR À/À animals. As C5aR À/À BMNCs did not respond to desArg C5a, in contrast to wt BMNCs (Figures 3c and d) , this fact demonstrates that C5aR, but not C5L2, is involved in migration of BMNCs.
Finally, we analyzed the expression of both C5 cleavage fragment receptors (C5aR and C5L2) on murine BMNCs. Figure 4a shows that murine SKL cells that are enriched for HSPCs, in contrast to neutrophils (Gr-1 þ cells) and monocytes (CD14 þ cells), do not express mRNA for C5aR and C5L2. However, a low expression of mRNA for C5L2 receptor becomes visible in Gr-1 þ and CD14 þ cells first after 435 cycles of amplification (not shown). Finally, FACS analysis confirmed no C5aR expression on murine SKL cells ( Figure 4b ).
Together, these data show that desArg C5a chemoattracts neutrophils and that this effect is mediated by C5aR.
Granulocytes are the first cells to egress from BM and release factors that increase responsiveness of HSPCs to SDF-1 gradient
As reported previously, CC becomes activated during mobilization in PB and cleavage of C5 releases C5a (short half-life), which is immediately converted to desArg C5a (long half-life). On the basis of our data that desArg C5a chemoattracts and activates granulocytes, we became interested in a potential role of these cells in egress of HSPCs from BM. First, by using kinetic studies, we confirmed that granulocytes are the first cells that egress from BM during mobilization (data not shown) preceding the egress of HSPCs. We assume that granulocytes, which are enriched in several proteolytic enzymes, somehow 'pave the way' to facilitate the egress of HSPCs. To support this our real-time reverse transcriptase-polymerase chain reaction data revealed that Gr-1 þ BMNCs express MMP-9 at a 4100 times higher level than purified SKL cells and that this expression is additionally upregulated B2 times after C5a and desArg C5a stimulation.
Next, to evaluate whether granulocytes after release into BM vessels secrete some factors affecting the subsequent egress of HSPCs, we purified Gr-1 þ cells from BM by FACS. Subsequently, these Gr-1 þ cells were non-stimulated (control) or stimulated with C5a or desArg C5a, and conditioned media (CM) were harvested and used in chemotactic assays. We noticed that, although these CM alone had a very weak chemotactic activity (data not shown), CM harvested from C5a, but not from desArg C5a stimulated Gr-1 þ BM-cells enhanced SDF-1-mediated chemotaxis of BMNCs and CFU-GM ( Figures  5a and b) . As a similar effect was not observed for CM harvested from Gr-1 þ BM-derived cells isolated from C5aR À/À animals (Figures 5c and d) , we concluded that this effect was C5aR dependent and C5L2 could not compensate for the C5aR absence on Gr-1 þ cells.
Cationic peptides released from granulocytes enhance responsiveness of HSPCs to SDF-1 gradient
To address which factors released from granulocytes stimulated by C5a increase responsiveness of HSPCs to SDF-1 gradient, we focused on granulocyte-derived cationic peptides that, as reported by us, C3a may interact with on the cell membrane surface in a nonreceptor-mediated manner. 10, 14, 28 We selected four potential candidates: lactoferrin; b-defensin-1 (hBD-1); b-defensin-2 (hBD-2); and active fragment of cathelicidin (LL-37). Figure 5 shows that LL-37 and hBD-2, which alone do not show chemotactic activity (data not shown), enhance/prime migration of BMNCs (Figure 5e ) and CFU-GM (Figure 5f ) to low doses of SDF-1. To our surprise, this hBD-2 and LL-37 'priming' effect was several times higher than those described by us previously for C3a. 10, 16 We reported earlier that enhanced responsiveness of HSPCs to SDF-1 gradient in the presence of C3a (priming effect) is mediated by a C3a nonreceptor-mediated incorporation of Innate immunity and stem cell mobilization HM Lee et al CXCR4 into membrane lipid rafts. 10, 14 We postulated that CXCR4 incorporated into membrane lipid rafts is better connected to downstream signaling machinery and responds robustly to an SDF-1 gradient. Figure 6a shows that both hBD-2 and LL-37 also increase the incorporation of CXCR4 into membrane lipid rafts. This was subsequently confirmed in chemotactic assays after perturbation of lipid raft formation by exposure of cells to cell membrane cholesterol-depleting agent, methyl-b-cyclodextran. Figure 6b shows that exposure of cells to methyl-b-cyclodextran inhibited LL-37-enhanced responsiveness to SDF-1 gradient. In control experiments, this pretreatment did not affect N-Formyl-L-methionyl-L-leucyl-Lphenylalanine-mediated migration (data not shown), which uses G-protein-independent and non-lipid raft-associated N-Formyl-L-methionyl-L-leucyl-L-phenylalanine receptor. 29 
Discussion
The process of HSPC mobilization is still not fully understood and a significant number of patients, particularly those with previous histories of chemotherapy, are poor mobilizers. 30, 31 G-CSF is currently the most frequently used clinical drug that may efficiently mobilize HSPCs after a few consecutive daily injections. [5] [6] [7] Mobilization could also be induced within hours after the administration of some chemokines (for example, IL-8, growth-related oncogene protein-b (Gro-b), macrophage inhibitory protein-1 a (MIP-1a)) or small molecular CXCR4 receptor antagonists (for example, AMD3100, T140). 32 In addition, in experimental animals, mobilization also occurs within 1 h after a single injection of selected polysaccharides (for example, zymosan, fucoidans). 33 Cationic peptides released from granulocytes enhance responsiveness of HSPCs to SDF-1 gradient. CM, prepared by incubating Gr-1 þ cells (2 Â 10 6 /ml) for 1 h with C5 cleavage fragments (CC, no stimulation; CA, stimulated with C5a; CB, stimulated with desArg C5a), was added into lower wells (final concentration 50%) to evaluate the priming effect of granules released from granulocytes. CM of Balb/c mice granulocytes, stimulated with C5a but not desArg C5a enhanced the responsiveness of C5aR À/À BMNCs (a) and CFU-GM progenitor cells (b) to SDF-1 gradient. In contrast, CM of C5aR À/À mice granulocytes did not enhance the responsiveness of C5aR À/À BMNCs (c) or CFU-GM progenitor cells (d).
Recombinant cationic peptides LL-37 and hBD-2 strongly enhanced migration of BMNCs (e) and CFU-GM progenitor cells (f) in response to SDF-1 gradient. Values are the fold increases of migrated cells compared with those of media alone. M, media alone; SDF-1 (L), 50 ng/ml; SDF-1 (H), 300 ng/ml; C3a, 1 mg/ml. *Po0.05 as compared with SDF-1 (50 ng/ml) alone. The data shown represent the combined results from four independent experiments carried out in triplicate per group (n ¼ 12).
Several host-related factors have been described to regulate mobilization, including (i) the release of proteases in the BM microenvironment by activated myeloid cells, which perturb interactions of SDF-CXCR4, VLA-4-VCAM-1 and KL-c-KitR axes; 9,20,21 (ii) the release of neurotransmitters in the BM microenvironment by neural fibers that innervate BM; 35 (iii) the downregulation of SDF-1 expression in osteoblastic stem cell niches; 36, 37 (iv) the activation of osteoclasts; 38 and (v) the upregulation of serpin family protease inhibitors. 39, 40 Recent evidence shows that mobilization of HSPCs is also regulated by several components of innate immunity, including CC [10] [11] [12] 14, 16, 17 and granulocytes. 13, 14, 41 Accordingly, we reported that, for example, G-CSF and cyclophosphamide or zymosan infusion strongly activates CC in BM by a classical pathway because of exposure of neo-epitope during mobilization on the surface of damaged BMNCs. 11, 42, 43 This neo-epitope binds naturally occurring antibodies, and neoepitope-NAb complexes circulating in PB through C1q trigger the classical immunoglobulin (Ig)-dependent pathway of CC activation. In addition, because G-CSF activates the coagulation system, thrombin has recently been identified as an underappreciated CC activator. 44 In contrast, zymosan as a polysaccharide may directly activate CC by using factor B and D involving the Ig-independent alternative CC activation pathway. The crucial role of CC in mobilization of HSPCs was demonstrated in experiments in mice with various defects of complement components. 10, 12, 14, 16, 17 We noticed that various CC components may have different roles and that mobilization could be regulated differently depending on the level of CC activation. For example, we reported that C3 À/À mice are easy mobilizers 17 and, in contrast, C5 À/À mice are poor mobilizers. 12, 14 Granulocytes are another important component of innate immunity required for HSPC mobilization; however, the mechanisms by which granulocytes induce mobilization are still not completely understood. On one hand, they were postulated to be a source of proteolytic enzymes in the BM that perturb HSPC retention signals. 9, 21, 22 On the other, in several mobilizing protocols, granulocytes were described as the first cells to egress from BM. To support this notion, mobilization of HSPCs is severely reduced in neutropenic mice. 13, 22, 23 In this study, we wanted to elucidate the molecular mechanisms underlying poor mobilization observed in C5 À/À animals. As C5-derived anaphylatoxins (C5a and desArg C5a) bind to G-protein-coupled, seven-transmembrane span C5a receptors (C5aR and C5L2) that are expressed on granulocytes, we became interested in a link between the major components of innate immunity, such as C5a and desArg C5a anaphylatoxins and egress of granulocytes and subsequent mobilization of HSPCs.
Our C5aR and C5L2 receptor expression analysis revealed that hematopoietic stem cells do not express C5 cleavage fragment receptors on the surface. This was subsequently supported by functional chemotaxis studies on C5a and desArg C5a that revealed that BMNCs, but not purified SKL cells show chemotaxis to C5 cleavage fragments. Furthermore, both C5 cleavage fragments, in contrast to C3 cleavage fragments, 10, 16 did not enhance (prime) chemotactic responsiveness of HSPCs to low/threshold levels of SDF-1.
However, both C5 cleavage fragments affected several important neutrophil-dependent steps of HSPC mobilization (Figure 7) . First, in addition to their ability to increase the secretion of proteases by granulocytes, 9, 21, 22 C5 cleavage fragments induce their egress from BM ( desArg C5a). Subsequently, these fragments in BM vessels (C5a) stimulate the release of several factors that, as we showed in this paper, enhance the responsiveness of HSPCs to SDF-1 gradient. As these effects were not visible in C5aR À/À mice, this suggests a crucial involvement of C5aR, but not of the C5L2 receptor, in this phenomenon.
On the basis of this, we envision that granulocytes are the first cells to egress from BM in response to desArg C5a. As they highly express various proteases (for example, metalloproteinases) necessary for cell migration through the endothelial barrier, they somehow facilitate a subsequent egress of HSPCs, which express these enzymes at much lower levels ('ice breaker mechanism') ( Figure 7 ). However, we are aware that, in addition to desArg C5a, other factors may also facilitate the egress of neutrophils from BM (for example, IL-8, NAP-2, Gro-b). Therefore, some compensatory overlapping mechanisms exist that still maintain some level of granulocyte egress and HSPCs mobilization in C5 À/À animals.
Of importance in this report, we identified for the first time that several plasma-derived cationic peptides (cathelicidin and b-defensin-2) that are released by activated granulocytes (for example, after stimulation by C5a) 14, 45, 46 show strong priming effects that increase the responsiveness of HSPCs to the SDF-1 gradient. This phenomenon, as initially described for C3 cleavage fragments (C3a and desArg C3a anaphylatoxins), 10, 28, 47 is based on nonreceptor-mediated interactions of these proteins, which also possess a cationic structure, with the cell membrane. We reported that this C3a-and desArg C3a-mediated interaction leads to lipid raft formation on the surface of target cells. 10 As the CXCR4 receptor requires incorporation into membrane lipid rafts for optimal signaling, priming by C3a, desArg C3a or, as shown here for the first time, by granulocyte-derived cathelicidin and b-defensin-2 increases the incorporation of this receptor into lipid rafts. As a result, CXCR4 is better associated with downstream signal transduction proteins and responds more robustly to low/threshold levels of SDF-1. Thus, On the basis of this, our data indicate that cathelicidin and b-defensin-2 released from granulocytes in a C5a-C5aR-dependent manner facilitate the egress of HSPCs from BM by enhancing lipid raftdependent priming of HSPCs to plasma SDF-1 levels (Figure 7 ). Finally, further work is needed to evaluate the direct effect of C5 cleavage fragments on the permeability of the BM endothelium, which is currently being investigated in our laboratory.
In conclusion, our data show a central role of innate immunity and better explain the involvement of granulocytes and C5 cleavage fragments in the mobilization of HSPCs. Granulocytes and C5 cleavage fragments orchestrate this process and, in light of our presented data, mobilization of HSPCs could be envisioned as being a part of the innate immunity response. With CC activation also observed during inflammation 16, 48 and tissue/organ injury, 49, 50 this phenomenon has broader implications. Although HSPCs mobilized from BM during infection may patrol peripheral tissues and thus have an important role in host defense, 1,2 other types of BM-derived stem cells may be released to act in the regeneration of damaged tissues. 3, 4, 43 To support this concept in all these processes, both CC activation and granulocytosis are involved. 
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Stromal cell Figure 7 C5 cleavage fragments have an important role in granulocyte egress and HSPCs mobilization from BM. There are three levels at which C5 cleavage fragments (C5a and desArg C5a) affect granulocytes and thus affect HSPC mobilization. First, stimulation of granulocytes in the BM microenvironment by C5a and desArg C5a enhances the secretion of proteolytic enzymes, which perturb HSPC retention signals (for example, SDF-1-CXCR4 and VLA-4-VCAM-1 interactions) (Step I). Second, serum desArg C5a chemoattractants induce egress of HSPCs from BM into PB. Migrating from BM into PB, granulocytes rich in metalloproteinases 'pave the way' for HSPCs, which follow granulocytes and migrate through the endothelial barrier ('ice breaker phenomenon') (Step II). Finally, after egress from BM, granulocytes are stimulated in BM vessels by C5a and release several cationic peptides, some of which (for example, cathelicidin, b-defensin-2) enhance/prime the responsiveness of HSPCs to serum levels of SDF-1 (Step III) . Finally, we cannot exclude the potential direct effect of C5 cleavage fragments on the permeabilization of endothelium, which requires further studies.
